OZ.VGI.CO.ID - In Kingston, Rhode Island, a new research initiative is addressing a critical gap in preventive healthcare conversations. The University of Rhode Island (URI) College of Nursing has launched a study to understand how healthcare practitioners perceive and communicate the link between alcohol consumption and breast cancer risk. Announced on August 20, 2026, this effort responds to evolving scientific evidence and changing public health guidelines that can leave both patients and providers confused.
The B-SMART Study: Investigating Provider Knowledge and Practices
The Breast Cancer Screening & Moderation of Alcohol for Risk Transformation (B-SMART) study is designed to examine the knowledge, attitudes, and current clinical practices of nurse practitioners and physicians regarding alcohol use and its associated risk for breast cancer in women. The research team aims to uncover not just what providers know, but how that knowledge translates into patient counseling.
Lead researchers Patricia Cioe, URI nursing Associate Dean for Research and Scholarship, and Assistant Professor Erica Liebermann, will conduct in-depth interviews with healthcare providers across Rhode Island. Through structured Zoom sessions, they will explore providers' perceptions of the alcohol-breast cancer link, the information they share with patients, and the barriers that prevent these vital conversations from happening.
Personal Experience Sparks a New Research Direction
The B-SMART study has its roots in a broader working group at the Brown University School of Public Health, where Dr. Cioe serves as an adjunct professor. That group initially focused on patient awareness during breast cancer screenings like mammography. However, a pivotal personal encounter reshaped the research focus entirely.
"I just happened to ask my healthcare provider their perspective regarding alcohol and breast cancer, and found my provider was not very concerned and said they did not talk with their patients about it," Cioe explained. This experience highlighted a potential disconnect between established medical knowledge and routine clinical practice, prompting a shift toward studying provider perspectives.
Navigating Shifting Guidelines on Alcohol and Cancer Risk
A core challenge in this field is the evolution of official health recommendations. For years, guidelines from institutions like the National Institute on Alcohol Abuse and Alcoholism suggested moderate drinking—one drink per day for women, two for men—was safe. However, more recent advisories, notably from the U.S. Surgeon General, state that no level of alcohol consumption is considered completely safe, and even one drink daily can increase cancer risk.
This shift from "moderation is acceptable" to "no level is safe" creates a complex communication landscape. Providers must not only stay current with emerging data but also translate often-ambiguous findings into clear, actionable advice for patients who may be comfortable with older, more permissive guidelines.
Why Providers May Struggle to Have the Conversation
Dr. Liebermann, a nurse practitioner and women's health expert, suggests the issue may go beyond simple awareness. "There may be limited awareness among practitioners of the association, but I think it probably has more to do with practitioners not feeling inclined or equipped to talk to patients about it," she stated. This points to a need for effective communication tools and training.
The B-SMART study seeks to identify precisely what those barriers are—whether they are time constraints, a lack of conversational scripts, fear of judgment, or uncertainty about the strength of the evidence. Understanding these obstacles is the first step toward removing them and integrating alcohol-risk counseling into standard care.
Recruitment and Long-Term Goals for Impact
Currently, the research team is actively recruiting 20-25 physicians and nurse practitioners from across Rhode Island to participate in the study. Healthcare providers interested in contributing to this important work can visit the project's research website or contact the team directly at projectBSMART2026@gmail.com.
This investigation is explicitly positioned as a foundational step. "This is our first step in developing a line of research," said Cioe. "This is information gathering to better understand the issue, with the goal of potentially developing an educational program for healthcare providers and for patients." The ultimate aim is to transform these insights into tangible resources that enhance patient education and support provider practice.
Frequently Asked Questions (FAQ)
What is the primary goal of the URI B-SMART study?
The primary goal is to understand healthcare providers' current knowledge, attitudes, and practices concerning the association between alcohol use and breast cancer risk, and how they communicate this information to patients. The findings will inform the development of future educational programs.
Why is there a need for this study now?
The study is needed because official guidelines on safe alcohol consumption have evolved, with newer advice stating no level of alcohol is safe for cancer prevention. This creates confusion for both patients and providers, and it's unclear how effectively practitioners are navigating and communicating these updated findings.
Who can participate in the B-SMART study?
The researchers are recruiting 20-25 licensed physicians and nurse practitioners currently practicing in Rhode Island. Interested healthcare providers are encouraged to contact the team via the provided email address for more information on eligibility and participation.
How does alcohol specifically increase breast cancer risk?
Research indicates alcohol can increase estrogen and other hormone levels linked to hormone-receptor-positive breast cancers. It may also damage DNA in cells, interfere with nutrient absorption (like folate), and act as a solvent, making it easier for other carcinogens to enter cells. Even moderate consumption is associated with an increased risk.
Comments